Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization

Shingo Satofuka, Atsuhiro Ichihara, Norihiro Nagai, Takashi Koto, Hajime Shinoda, Kousuke Noda, Yoko Ozawa, Makoto Inoue, Kazuo Tsubota, Hiroshi Itoh, Yuichi Oike, Susumu Ishida

研究成果: Article

61 引用 (Scopus)

抄録

PURPOSE. Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the present study was to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization. METHODS. C57BL/6 neonatal mice were reared in an 80% concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1, and VEGFR-2 were examined by RT-PCR and ELISA. RESULTS. Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1, and VEGFR-2 in ischemic retinopathy were also significantly suppressed by the application of HRP. CONCLUSIONS. The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.

元の言語English
ページ(範囲)422-429
ページ数8
ジャーナルInvestigative Ophthalmology and Visual Science
48
発行部数1
DOI
出版物ステータスPublished - 2007 1

Fingerprint

Physiologic Neovascularization
Retinal Neovascularization
Renin
Vascular Endothelial Growth Factor Receptor
Vascular Endothelial Growth Factor Receptor-1
Retinal Vessels
Peptides
Intercellular Adhesion Molecule-1
Leukocyte Count
Ischemia
Pathologic Neovascularization
Messenger RNA
Uveitis
Renin-Angiotensin System
Concanavalin A
Intraperitoneal Injections
Lectins
Endotoxins
Vascular Endothelial Growth Factor A
Respiration

ASJC Scopus subject areas

  • Ophthalmology

これを引用

Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. / Satofuka, Shingo; Ichihara, Atsuhiro; Nagai, Norihiro; Koto, Takashi; Shinoda, Hajime; Noda, Kousuke; Ozawa, Yoko; Inoue, Makoto; Tsubota, Kazuo; Itoh, Hiroshi; Oike, Yuichi; Ishida, Susumu.

:: Investigative Ophthalmology and Visual Science, 巻 48, 番号 1, 01.2007, p. 422-429.

研究成果: Article

Satofuka, Shingo ; Ichihara, Atsuhiro ; Nagai, Norihiro ; Koto, Takashi ; Shinoda, Hajime ; Noda, Kousuke ; Ozawa, Yoko ; Inoue, Makoto ; Tsubota, Kazuo ; Itoh, Hiroshi ; Oike, Yuichi ; Ishida, Susumu. / Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. :: Investigative Ophthalmology and Visual Science. 2007 ; 巻 48, 番号 1. pp. 422-429.
@article{776a25251a73486c93558c86dfd6313a,
title = "Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization",
abstract = "PURPOSE. Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the present study was to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization. METHODS. C57BL/6 neonatal mice were reared in an 80{\%} concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1, and VEGFR-2 were examined by RT-PCR and ELISA. RESULTS. Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1, and VEGFR-2 in ischemic retinopathy were also significantly suppressed by the application of HRP. CONCLUSIONS. The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.",
author = "Shingo Satofuka and Atsuhiro Ichihara and Norihiro Nagai and Takashi Koto and Hajime Shinoda and Kousuke Noda and Yoko Ozawa and Makoto Inoue and Kazuo Tsubota and Hiroshi Itoh and Yuichi Oike and Susumu Ishida",
year = "2007",
month = "1",
doi = "10.1167/iovs.06-0534",
language = "English",
volume = "48",
pages = "422--429",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "1",

}

TY - JOUR

T1 - Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization

AU - Satofuka, Shingo

AU - Ichihara, Atsuhiro

AU - Nagai, Norihiro

AU - Koto, Takashi

AU - Shinoda, Hajime

AU - Noda, Kousuke

AU - Ozawa, Yoko

AU - Inoue, Makoto

AU - Tsubota, Kazuo

AU - Itoh, Hiroshi

AU - Oike, Yuichi

AU - Ishida, Susumu

PY - 2007/1

Y1 - 2007/1

N2 - PURPOSE. Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the present study was to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization. METHODS. C57BL/6 neonatal mice were reared in an 80% concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1, and VEGFR-2 were examined by RT-PCR and ELISA. RESULTS. Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1, and VEGFR-2 in ischemic retinopathy were also significantly suppressed by the application of HRP. CONCLUSIONS. The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.

AB - PURPOSE. Recently, it was revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the present study was to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization. METHODS. C57BL/6 neonatal mice were reared in an 80% concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1, and VEGFR-2 were examined by RT-PCR and ELISA. RESULTS. Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1, and VEGFR-2 in ischemic retinopathy were also significantly suppressed by the application of HRP. CONCLUSIONS. The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.

UR - http://www.scopus.com/inward/record.url?scp=33846902147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846902147&partnerID=8YFLogxK

U2 - 10.1167/iovs.06-0534

DO - 10.1167/iovs.06-0534

M3 - Article

C2 - 17197563

AN - SCOPUS:33846902147

VL - 48

SP - 422

EP - 429

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 1

ER -